Allison M Kade
Overview
Explore the profile of Allison M Kade including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fletcher J, Kade A, Sheehan K, Wilson T
J Clin Neurosci
. 2014 Apr;
21(8):1323-8.
PMID: 24685012
Mannitol has been shown to damage endothelial cells and activate coagulation pathways leading to intravascular thrombosis. Dehydration and hemagglutination have also been associated with mannitol use, although the risk of...
2.
Fletcher J, Meurer W, Dunne M, Rajajee V, Jacobs T, Sheehan K, et al.
Neurocrit Care
. 2013 Dec;
20(2):263-9.
PMID: 24366680
Background: Neurocardiogenic injury results from increased sympathetic nervous system activation following acute brain injury. No diagnostic criteria for neurocardiogenic injury exist, and agreement has not been tested. We investigated the...
3.
Meurer W, Sozener C, Xu Z, Frederiksen S, Kade A, Olgren M, et al.
West J Emerg Med
. 2013 Mar;
14(1):16-22.
PMID: 23447752
Introduction: Emergency physician (EP) turnover is a significant issue that can have strong economic impact on hospital systems, as well as implications on research efforts to test and improve clinical...
4.
Meurer W, Kwok H, Skolarus L, Adelman E, Kade A, Kalbfleisch J, et al.
Acad Emerg Med
. 2013 Feb;
20(2):146-54.
PMID: 23406073
Objectives: Intracranial hemorrhage (ICH) after acute stroke thrombolysis is associated with poor outcomes. Previous investigations of the relationship between preexisting antiplatelet use and the safety of intravenous (IV) thrombolysis have...
5.
Skolarus L, Scott P, Burke J, Adelman E, Frederiksen S, Kade A, et al.
Stroke
. 2012 Oct;
43(12):3392-4.
PMID: 23033348
Background And Purpose: Identifying modifiable tissue plasminogen activator treatment delays may improve stroke outcomes. We hypothesized that prethrombolytic antihypertensive treatment (AHT) may prolong door-to-treatment time (DTT). Methods: We performed an...
6.
Meurer W, Majersik J, Frederiksen S, Kade A, Sandretto A, Scott P
BMC Emerg Med
. 2011 May;
11:5.
PMID: 21548943
Background: Only 1-3% of ischemic stroke patients receive thrombolytic therapy. Provider barriers to adhering with guidelines recommending tPA delivery in acute stroke are not well known. The main objective of...
7.
Langenecker S, Saunders E, Kade A, Ransom M, McInnis M
J Affect Disord
. 2009 Oct;
122(3):285-93.
PMID: 19800130
Background: Intermediate cognitive phenotypes (ICPs) are measurable and quantifiable states that may be objectively assessed in a standardized method, and can be integrated into association studies, including genetic, biochemical, clinical,...
8.
Wright S, Langenecker S, Deldin P, Rapport L, Nielson K, Kade A, et al.
Depress Anxiety
. 2008 Sep;
26(2):182-9.
PMID: 18800371
Background: One of the principal theories regarding the biological basis of major depressive disorder (MDD) implicates a dysregulation of emotion-processing circuitry. Gender differences in how emotions are processed and relative...